Liver Gene Therapy
Immortomouse Hepatocytes Evaluated for Use as Test Model
Published in Gene Therapy Weekly, February 22nd, 2001
"The use of hepatocytes for gene therapy is limited by the difficulty of maintaining and altering primary liver cells in culture," wrote K.J. Allen and colleagues, Royal Children's Hospital, Victoria. "A conditionally immortalized mouse hepatocyte cell line has been developed which can be passaged indefinitely at the permissive temperature (33(degree)C), but fails to proliferate and dies at the non-permissive temperature (39(degree)C) in vitro."
Allen et al. published their study in the Journal of Gastroenterology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2001-02-22)
More Articles from Gene Therapy Weekly
- Allograft Rejection
Synthetic Gene Delivery Safely Targets Vascular Smooth Muscle Cells - Parkinson's Disease
Gene Therapy Approach Protects Against Neuronal Death - Cancer Gene Therapy
Suicide Potential of Fruitfly Nucleoside Kinase Explored - Immunosuppression
Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells - Cancer Gene Therapy
Expression of Angiogenesis Inhibitor Suppresses Neuroblastoma Growth - Lung Disease
Treatment Might Include Gene Therapy and Designer Antibiotics - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
